Safety and efficacy of Wharton’s jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study

Shim, J., Kim, K., Kim, K. G., Choi, U., Kyung, J. W., Sohn, S., Lim, S. H., Choi, H., Ahn, T., Choi, H. J., Shin, D. and Han, I.  Safety and efficacy of Wharton’s jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study.  STEM CELLS Translational Medicine. 2020.  doi: 10.1002/sctm.20-0308

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.